Endocrinology · Lady Lake, FL
NPI
1437197860
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
918 Rolling Acres Rd, Suite #6
Lady Lake, FL, 32159
Phone (352) 259-9970
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
1,482 services
Medicare patients, 2024
561
Average age 76
Drug cost, 2024
$2.1M
3,416 prescriptions
Company payments, 2025
$260
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michel S Habashy was code 99214 (office e&m - established), 1,216 times for 497 patients. In total Michel S Habashy billed 1,482 services in 4 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,216 | 497 | $89.52 | $109K |
| 99204 Office E&M - New | Office | 163 | 163 | $119.04 | $19K |
| 99213 Office E&M - Established | Office | 100 | 85 | $64.82 | $6,482 |
By year: 2022 $126K for 1,454 services; 2023 $119K for 1,351 services; 2024 $135K for 1,482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michel S Habashy prescribed most often to Medicare patients was Levothyroxine Sodium, with 430 prescriptions and refills. In total Michel S Habashy wrote 3,416 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 430 | 1,270 | 125 | $5,700 |
| Ozempic Semaglutide | 303 | 553 | 64 | $514K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 189 | 494 | 65 | $275K |
| Glimepiride Generic | 169 | 485 | 53 | $2,155 |
| Jardiance Empagliflozin | 148 | 408 | 49 | $224K |
| Rosuvastatin Calcium Generic | 145 | 436 | 53 | $3,061 |
| Mounjaro Tirzepatide | 144 | 192 | 28 | $190K |
| Synthroid Levothyroxine Sodium | 122 | 353 | 39 | $12K |
| Metformin Hcl Generic | 113 | 338 | 42 | $1,158 |
| Trulicity Dulaglutide | 97 | 158 | 23 | $147K |
| Pioglitazone Hcl Generic | 90 | 262 | 36 | $1,632 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 73 | 191 | 24 | $97K |
| Amlodipine Besylate Generic | 63 | 189 | 22 | $368 |
| Synjardy Empagliflozin/Metformin Hcl | 55 | 133 | 20 | $76K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 52 | 145 | 21 | $5,167 |
Brand drugs: 1,991 claims; generic drugs: 1,295 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michel S Habashy $260 ($260 in general payments such as food, travel and fees) from 7 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $77.31.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.